Mariangela Librizzi
Palermo, 90128, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Natural Anticancer Peptides from Marine Animal Species: Evidence from In Vitro Cell Model Systems.
Journal: Cancers
Published: November 29, 2023
Parathyroid hormone-related protein (PTHrP)-dependent modulation of gene expression signatures in cancer cells.
Journal: Vitamins and hormones
Published: August 11, 2022
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.
Journal: Autophagy
Published: February 26, 2021
Mid-region parathyroid hormone-related protein is a genome-wide chromatin-binding factor that promotes growth and differentiation of HB2 epithelial cells from the human breast.
Journal: BioFactors (Oxford, England)
Published: October 15, 2018
Molecular Signatures Associated with Treatment of Triple-Negative MDA-MB231 Breast Cancer Cells with Histone Deacetylase Inhibitors JAHA and SAHA.
Journal: Chemical research in toxicology
Published: November 14, 2017
Biological Effect of a Hybrid Anticancer Agent Based on Kinase and Histone Deacetylase Inhibitors on Triple-Negative (MDA-MB231) Breast Cancer Cells.
Journal: International journal of molecular sciences
Published: May 18, 2016
The Histone Deacetylase Inhibitor JAHA Down-Regulates pERK and Global DNA Methylation in MDA-MB231 Breast Cancer Cells.
Journal: Materials (Basel, Switzerland)
Published: August 29, 2015
The conditioned medium from osteo-differentiating human mesenchymal stem cells affects the viability of triple negative MDA-MB231 breast cancer cells.
Journal: Cell biochemistry and function
Published: May 25, 2015
Cytotoxicity of the Urokinase-Plasminogen Activator Inhibitor Carbamimidothioic Acid (4-Boronophenyl) Methyl Ester Hydrobromide (BC-11) on Triple-Negative MDA-MB231 Breast Cancer Cells.
Journal: Molecules (Basel, Switzerland)
Published: March 04, 2015
Last Updated: 09/26/2026